EGCG bioavailability — what's measured in human plasma

Epigallocatechin gallate — EGCG — is the most abundant and most studied catechin in green tea, and its name appears on supplement labels, wellness blogs, and in the methods sections of hundreds of clinical trials. A typical cup of Lǜ Chá (绿茶) might deliver anywhere from 50 to 200 mg of EGCG, depending on leaf, liquor and technique. But the jump from cup to bloodstream is anything but direct. When researchers draw blood from participants who have just swallowed a carefully prepared dose of tea or tea extract, the EGCG concentration that shows up in plasma is often less than one percent of what was ingested. That stubborn gap — between what the tea gives and what the body keeps — is the bioavailability question, and it shapes everything from the design of intervention studies to the way we talk about tea’s health potential. In this article we walk through the pharmacokinetic numbers that actually appear in the human plasma literature, the physiological barriers that create those numbers, and what it all means for someone who drinks tea every day.

Ecgg and the wall of the gut

Before EGCG can appear in plasma, it must cross a formidable set of barriers: the gut lumen, the enterocyte, and the liver. The molecule is large — 458 daltons — and densely decorated with hydroxyl groups that make it extremely hydrophilic yet also prone to binding food proteins and digestive enzymes. Passive diffusion through the lipid bilayer of intestinal cells is negligible. Instead, EGCG relies on organic anion‑transporting polypeptides (OATPs) and other membrane carriers to gain entry, while efflux transporters such as P‑glycoprotein actively pump it back into the gut lumen. The net result is that oral bioavailability in rodents, measured as the fraction of unchanged drug reaching systemic circulation, rarely exceeds 5 percent, and human data point to a similar figure. Dr. Joshua Lambert, whose lab at Penn State has mapped catechins’ cellular trafficking, describes the situation bluntly: “EGCG is a molecule that evolution never anticipated we’d eat in gram quantities — almost every gatekeeper system we have tries to keep it out.” This first‑pass effect — gut wall plus liver metabolism — means that plasma concentrations after a realistic tea dose are measured in the low nanograms per millilitre, not the milligrams one might expect.

What a typical plasma curve looks like

In the most cited human pharmacokinetic study to date, Ullmann and colleagues gave 200 mg of purified EGCG to fasting volunteers and found a mean maximum plasma concentration (Cmax) of just 77 ng/mL, reached about 1.6 hours after ingestion. A decade earlier, Chow’s group at the University of Arizona reported similar numbers after a single 200 mg dose of Polyphenon E, a decaffeinated green tea extract: Cmax around 55 ng/mL for EGCG, with a half‑life of roughly 3.4 hours. These values are tiny when compared with the 200 mg oral dose — they represent less than 0.1% of the ingested mass circulating in whole blood at any moment. The time‑concentration curve is bell‑shaped but shallow; after the peak, levels drop back toward baseline by 8 to 12 hours, and no marked accumulation is seen with once‑daily dosing. What’s more, the plasma EGCG measured is overwhelmingly not free EGCG: roughly 70–90% is conjugated — glucuronidated, sulfated, or methylated — by phase II enzymes in the gut and liver.

Conjugated forms dominate in plasma

This high conjugation rate matters because it changes the biological reach of EGCG. Methyl‑EGCG has different polarity, different protein‑binding affinity, and potentially different intracellular signalling effects than parent EGCG. When an analytical lab reports “total EGCG” in plasma, they are usually summing free and conjugated forms after enzymatic deconjugation — so the figure that appears in tables already paints a larger number than what circulates in its native state. Chen Hui Yi, Senior Tea Expert at tea.doctor, notes that “tea chemists often forget this nuance. The EGCG we measure in the cup with the GB/T 8313 method is free catechin; the plasma figure is predominantly decorated. Comparing them is like comparing a fresh apple to a baked one — same family, different properties.” These conjugates may be reservoirs that slowly release free EGCG at tissues, but the direct measurement of free EGCG in blood is vanishingly low.

Food effects — not just an empty stomach myth

The decision to drink tea with or without food changes the pharmacokinetic result more than almost any other variable. When Chow’s team in 2005 asked volunteers to take Polyphenon E either fasting or after a standardised high‑fat breakfast, the fasted Cmax for EGCG was more than five times higher than the fed Cmax. The mechanism appears to be two‑fold: food physically slows gastric emptying, so catechins dribble into the small intestine instead of arriving as a bolus; and proteins in the meal — especially casein — can bind catechins, forming complexes that cannot cross the enterocyte. A 2020 meta‑analysis of food‑catechin interaction studies pegged the average reduction in EGCG bioavailability with food at roughly 40–70%, depending on the macronutrient composition. For tea drinkers, the practical implication is clear: the EGCG peak from a post‑meal cup of Lóngjǐng (龙井) will be markedly lower than from the same tea sipped on an empty stomach — and that lower peak may be one reason why observational studies rarely report adverse effects from lifelong tea consumption.

Brewing and cultivar — the cup variability

Before bioavailability can be discussed, the dose in the cup must be defined, and it varies enormously. Chen Hui Yi has spent years measuring catechin extraction in Guangdong and Fujian labs. “When we brew Bái Háo Yín Zhēn (白毫银针) with water at 85 °C for three minutes, we extract roughly 60 mg of EGCG per gram of dry leaf,” she says, “but that number drops to under 20 mg if the leaf is second flush or the water barely reaches 70 °C.” For green teas, the range is even wider: a delicate Xīhú Lóngjǐng (西湖龙井) may yield 40–80 mg EGCG per gram, while a strong Japanese Yabukita cultivar can exceed 100 mg. However, most domestic tea drinkers do not use one gram of leaf per cup; a more realistic ratio is 3–5 g per 200 mL, so the EGCG dose is often between 120 and 400 mg per session — the upper end of that range approaching the doses used in many supplement trials. For a closer look at the numbers that actually end up in the liquor, see our companion article How much EGCG is actually in a real brew? The key point here is that bioavailability studies using precise 200 mg capsules often mask the wide daily variation in intake that a tea drinker experiences.

Leaf age and processing

Younger shoots contain more EGCG because synthesis of the molecule is part of the plant’s defence against insects and UV light; as the leaf matures, EGCG content declines. Fermentation — or any oxidation step — further erodes EGCG, which is why black tea typically delivers less than 10% of the EGCG of a comparable green tea. Chen Hui Yi’s lab has documented that a standard Kěemun (祁门红茶) brewed with 4 g leaf may contain only 5–15 mg EGCG, barely a blip on a pharmacokinetic radar. Aging too takes a toll: storage for just 12 months at ambient temperature can reduce catechin content in white tea by 20–30% (see our article Catechin breakdown across storage). For the daily drinker of a 10‑year‑aged Shòu Méi (寿眉), plasma EGCG after a session is likely negligible.

Supplements vs tea — does form matter?

Almost all the high‑dose pharmacokinetic data come from green tea extracts, not brewed tea. When a volunteer swallows a capsule containing 400 mg of EGCG‑enriched extract, their plasma Cmax can exceed 150 ng/mL, and sustained dosing over weeks can push trough levels into the detectable range. This is one reason why the liver‑safety warnings that accompany high‑dose supplements rarely apply to tea drinkers: the fasted, bolus intake of pure EGCG produces a systemic exposure that is simply not reached with infusions. A 2004 clinical study by Henning and colleagues directly compared green tea, black tea, and an EGCG‑standardised supplement, finding that the supplement yielded a plasma EGCG area‑under‑the‑curve (AUC) roughly twice that of the tea, despite similar total catechins ingested, likely because the tea matrix contains fibre and other polyphenols that slow absorption.

Green tea extract studies show higher Cmax, but also higher risk

This higher exposure comes with a cautionary note: reports of idiosyncratic liver injury, though rare, have been linked almost exclusively to high‑dose green tea extracts taken on an empty stomach. Food‑grade tea, by contrast, has a multi‑thousand‑year history of safety. For the curious mind, tea.doctor’s dedicated article How many cups is too many — the kidney-safety question explores the upper limits of everyday consumption. The bioavailability data reinforce the idea that tea is a gentle beverage, not a drug-delivery system; attempts to turn it into one by isolating and concentrating its constituents may defeat the very matrix that modulates its absorption.

Implications for daily tea drinking

If plasma EGCG peaks are in the low ng/mL range after a typical tea session, what does that say about the epidemiological observations linking tea to lower cardiovascular and metabolic risk? The answer lies in metabolites, gut microbiota interactions, and low‑grade signalling pathways that do not require high plasma titres. A 2022 review in Molecular Nutrition & Food Research noted that the urolithins and valerolactones produced by colonic bacteria from catechins may be the real effectors at work, with half‑lives far exceeding those of the parent compounds. Chen Hui Yi puts it succinctly: “Tea is not a medicine you dose; it is a daily rhythm. The plasma snapshot misses the whole‑body conversation that tea has been having with human biology for centuries.” For the tea‑lover, this means that the pleasure of the cup — its aroma, its texture, its moment of pause — does not require a blood test for validation. To explore the cognitive and stress‑related aspects of tea, see our articles on theanine during exam prep and at night, or visit tea.school for a broader course on tea polyphenols.

References

1. Ullmann U, et al. Plasma‑kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers. Eur J Clin Nutr. 2003;57(10):1276‑1284. — European Journal of Clinical Nutrition
2. Chow HHS, et al. Pharmacokinetics and safety of green tea polyphenols after multiple‑dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2001;7(6):1601‑1609. — Clinical Cancer Research
3. Chow HHS, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single‑dose administration of Polyphenon E in healthy individuals. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2346‑2352. — Cancer Epidemiology, Biomarkers & Prevention
4. Henning SM, et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr. 2004;80(6):1558‑1564. — American Journal of Clinical Nutrition
5. GB/T 8313‑2018. Tea — Determination of total polyphenols and catechins content. National Standard of the People's Republic of China. — Standardization Administration of China
6. Chen Hui Yi, Senior Tea Expert (White, Green & Yellow Tea Varieties), personal communication, 2024. — tea.doctor interview